Innogen · Research · Current projects
Internationalisation of Indian Pharma
In last decade leading Indian pharmaceutical firms has invested in acquisition of firms from overseas advance countries such as USA and Europe.
These new Indian MNEs are dominating global pharmaceutical markets and challenging existing paradigms of international business literature.
In this context this project tries to explore whether internationalisation of firms from developing countries can be explained in terms of mainstream theories derived mainly from studies of Western multinational corporations or do these cases present new insights in the explanations that have been offered for latecomer multinationals.
It investigates the patterns and motives of internationalisation by Indian pharmaceutical firms. It focuses on internalisation that is directed towards expansion into foreign markets and accessing new technologies through acquisitions.
This paper moves beyond study of export from domestic units and investigates different strategies adopted by Indian firms to internationalise their operations.
The 5 leading Indian firms are used as case studies and primary data was collected through interview with senior managers, scientists working in those organisations.
Aims and objectives
- Explore the nature and motives of recent FDI from Indian pharmaceutical firms in Europe and USA
- Contribute to theoretical debates in international business literaure regarding understanding of new phase of FDI from developing countries
- Develop new set of indictors to investigate the motive and nature of developing country FDI
Research will employ qualitative research methodology such as case study research.
Five leading Indian pharmaceutical firms which are at forefront in overseas acquisition will be used as case studies.
Primary data will be collected through interviews and content analysis will be used method for data analysis.